GluSense said yesterday that it received a $2 million grant from the Juvenile Diabetes Research Foundation’s T1D fund for the company’s injectable glucose sensor. Israel-based GluSense, part of Rainbow Medical, is developing the Glyde continuous glucose monitor for patients with Type I diabetes. The device is injected under the skin and lasts for 1 year, […]
Rainbow Medical
Johnson & Johnson unit inks spine implant development deal with Rainbow Medical
Rainbow Medical said today that it inked a deal with a unit of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes to co-develop a minimally invasive implant to treat degenerative disc disease. The deal between Medos International and Rainbow calls for development work to be carried out both in Israel and the U.S., including pre-clinical trials and laboratory tests, Herzliya, […]
SNN invests in Michelson’s Series B | Medtech funding for the week of February 16, 2015
Rainbow Medical raises $25m for China ops
Rainbow Medical said yesterday that it pulled down $25 million from a syndicate of Chinese investors for a new operation in the People’s Republic, aimed at promoting "strategic collaborations" there.
Sony puts $10M into Israeli medical device portfolio company Rainbow Medical
Technology giant Sony Corp. (TYO:6758) invested $10 million into Israel-based Rainbow Medical, a medical device portfolio company that has drawn other big players in the medtech industry.
Imaging3 loses director, president & COO Sohn | Personnel Moves
Imaging3 (OTC:IMGG) president & COO resigned "to pursue other interests," according to a regulatory filing, leaving the mobile fluoroscopy device maker without a replacement.
Sohn, whose resignation was effective March 31, was still listed on Imaging3’s website today. The company agreed to pay out $9,100 in severance, according to the filing.
